Cleared Traditional

K182886 - Cytomics FC 500 Series (MPL or MCL) Flow Cytometer

K182886 is an FDA 510(k) clearance for Cytomics FC 500 Series (MPL or MCL) Flo..., manufactured by Beckman Coulter. The device is a Class 2 Immunology device with product code GKZ cleared through the Traditional 510(k) pathway after a 326-day FDA review.

K182886 · Beckman Coulter · Immunology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2019
Decision
326d
Days
Class 2
Risk

K182886 is an FDA 510(k) clearance for the Cytomics FC 500 Series (MPL or MCL) Flow Cytometer. Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Beckman Coulter (Miami, US). The FDA issued a Cleared decision on September 6, 2019 after a review of 326 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Immunology FDA review panel, regulated under 21 CFR 864.5220 - the FDA immunology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Immunology review framework, consistent with the majority of Class II 510(k) submissions.

View all Beckman Coulter devices

FDA 510(k) Submission Details - K182886

510(k) Number K182886 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 15, 2018
Decision Date September 06, 2019
Days to Decision 326 days
Submission Type Traditional
Review Panel Immunology (IM)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
221d slower than avg
Panel avg: 105d · This submission: 326d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GKZ Device Classification - Class 2, Special Controls

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Immunology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 322
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K182886.
Athelas Home
K200828 · Athelas, Inc. · Mar 2022
Unicel DxH 800 Coulter Cellular Analysis System
K193124 · Beckman Coulter · Apr 2020
Sight OLO
K190898 · Sight Diagnostics , Ltd. · Nov 2019
CELL-DYN Emerald 22 AL System
K190294 · Abbott Laboratories · Mar 2019
DxH 520 Hematology Instrument
K181475 · Beckman Coulter · Mar 2019
Sysmex XN-L Automated Hematology Analyzer
K182389 · Sysmex America, Inc. · Jan 2019